In a new study of non-statin cholesterol-lowering medications, one type was linked to lower risks of liver cancer. The ...

Cholesterol-lowering medications, like ezetimibe, may cut liver cancer risk by 31%. Discover how this breakthrough could help ...

Current AHA guidelines call for healthy Americans to bring LDL below 100 milligrams per deciliter (mg/dL) of blood, while those who’ve had a heart attack or stroke are encouraged to drop LDL at least ...

To help prevent these deaths, drugs like statins can lower cholesterol, which stops unhealthy fat from building up and blocking your arteries. According to the American Heart Association (AHA ...

Esperion shares were up 13% to $3.16 after the company said it has filed New Drug Submissions to Health Canada for Nexletol and Nexlizet, non-statin medications that reduce low-density lipoprotein ...

Background Statin medications, used to prevent heart disease by reducing cholesterol, also reduce inflammation and protect against oxidative damage. As inflammation and oxidative stress occur in ...

ANN ARBOR, Mich., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 43rd Annual J.P. Morgan Healthcare Conference on ...

Esperion has filed New Drug Submissions to Health Canada for NEXLETOL and NEXLIZET, once-daily, accessible, oral non-statin medications that reduce low-density lipoprotein cholesterol and ...

Recent news on these stocks: December 2 Esperion has filed New Drug Submissions to Health Canada for NEXLETOL and NEXLIZET, once-daily, accessible, oral non-statin medications that reduce low ...